Envista Holdings Corporation NVST Specialty Products & Technologies — Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Envista Holdings Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Envista Holdings Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envista Holdings Corporation's specialty products & technologies — sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envista Holdings Corporation's specialty products & technologies — sales?
- Envista Holdings Corporation (NVST) reported specialty products & technologies — sales of $457.8M in Q1 2026.
- How has Envista Holdings Corporation's specialty products & technologies — sales changed year-over-year?
- Envista Holdings Corporation's specialty products & technologies — sales increased by 14.4% year-over-year, from $400.3M to $457.8M.
- What is the long-term trend for Envista Holdings Corporation's specialty products & technologies — sales?
- Over 4 years (2021 to 2025), Envista Holdings Corporation's specialty products & technologies — sales has grown at a 3.8% compound annual growth rate (CAGR), from $1.51B to $1.75B.
- What does specialty products & technologies — sales mean?
- The total revenue generated from the sale of dental implant systems, regenerative solutions, and associated software within the Specialty Products and Technologies segment. This is the primary measure of the segment's market demand and commercial success. It serves as a key indicator of the company's ability to monetize its specialized dental product offerings.